Literature DB >> 21626334

Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case.

Tatsuya Kato1, Keidai Ishikawa, Masaaki Satoh, Satoshi Kondo, Mitsuhito Kaji.   

Abstract

We herein report the case of a patient with Li-Fraumeni syndrome (LFS) who developed lung pleomorphic carcinoma. A 28-year-old female patient with a family history of early-onset malignancies was diagnosed with lung carcinoma and treated by surgical resection. Histological examination revealed a heterogeneous tumor with epithelial and mesenchymal components. The final pathological diagnosis was pulmonary pleomorphic carcinoma. In this patient, a constitutional mutation at codon 213 in exon 6 of the p53 gene was identified in the peripheral lymphocytes and the resected tumor, and LFS was suspected. This mutation causes a nonsense mutation (Arg-to-Stop codon) that has been shown to attenuate p53 function. This is the first report of pulmonary pleomorphic carcinoma developing in an LFS patient, and may suggest a relationship between germline p53 mutation and carcinogenesis in pulmonary pleomorphic carcinoma.

Entities:  

Mesh:

Year:  2011        PMID: 21626334     DOI: 10.1007/s00595-010-4359-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

Review 1.  Sarcomatoid carcinomas of the lung: a clinicopathologic review.

Authors:  M R Wick; J H Ritter; P A Humphrey
Journal:  Am J Clin Pathol       Date:  1997-07       Impact factor: 2.493

2.  Adult jejunojejunal intussusception caused by metastasized pleomorphic carcinoma of the lung: report of a case.

Authors:  Baomin Shi; Gereon Gaebelein; Bert Hildebrandt; Wilko Weichert; Matthias Glanemann
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  Pleomorphic carcinoma of the lung associated with loss of heterozygosity of p53 gene.

Authors:  Norimasa Arita; Yoshiki Mikami; Minako Yoshida; Ichiro Konishi; Norio Horiike; Katsutoshi Miyauchi; Tatsuhiko Miyazaki; Masato Nose; Masao Ono
Journal:  Tohoku J Exp Med       Date:  2005-06       Impact factor: 1.848

Review 5.  Germline TP53 mutations and Li-Fraumeni syndrome.

Authors:  J M Varley
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

Review 6.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  The p53 gene in pediatric therapy-related leukemia and myelodysplasia.

Authors:  C A Felix; M R Hosler; D Provisor; K Salhany; E A Sexsmith; D J Slater; N K Cheung; N J Winick; E A Strauss; R Heyn; B J Lange; D Malkin
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

8.  Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

Authors:  I Chiba; T Takahashi; M M Nau; D D'Amico; D T Curiel; T Mitsudomi; D L Buchhagen; D Carbone; S Piantadosi; H Koga
Journal:  Oncogene       Date:  1990-10       Impact factor: 9.867

9.  Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation.

Authors:  Y Horio; H Suzuki; R Ueda; T Koshikawa; T Sugiura; Y Ariyoshi; K Shimokata; T Takahashi; T Takahashi
Journal:  Oncogene       Date:  1994-04       Impact factor: 9.867

10.  Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.

Authors:  Shih-Jen Hwang; Li Shu-Chung Cheng; Guillermina Lozano; Christopher I Amos; Xiangjun Gu; Louise C Strong
Journal:  Hum Genet       Date:  2003-06-11       Impact factor: 4.132

View more
  1 in total

1.  Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Authors:  Michinori Funato; Yukiko Tsunematsu; Fumito Yamazaki; Chieko Tamura; Tadashi Kumamoto; Masatoshi Takagi; Shunsuke Kato; Haruhiko Sugimura; Kazuo Tamura
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.